{
  "chapter": "Cardiology-Ischemic Heart Disease",
  "questions": [
    {
      "q_no": 1,
      "question": "A 58-year-old male, who had a myocardial infarction one week ago, presents to the emergency department holding a clenched fist over his chest. Which biochemical marker would be most useful in confirming reinfarction in this patient?",
      "options": {
        "A": "Troponin",
        "B": "Creatine Kinase-MB",
        "C": "Lactate Dehydrogenase",
        "D": "Heart-type Fatty Acid-Binding Protein"
      },
      "correct_answer": "B",
      "explanation": "Correct Answer: B) Creatine Kinase-MB Explanation: The patient is displaying Levine's sign , a universal indicator of ischemic chest pain, where an individual holds a clenched fist over the chest. Although this sign has low sensitivity, it is relatively specific for ischemia. In this scenario, CK-MB is the most useful marker for confirming reinfarction , as its levels normalize within 48 to 72 hours after an initial infarction. Cardiac Biomarkers for Acute Myocardial Infarction (AMI): Acute MI\" data-author=\"NA\" data-hash=\"8712\" data-license=\"NA\" data-source=\"NA\" data-tags=\"April2025\" height=\"400\" src=\"https://image.prepladder.com/notes/Qlzxo33RAyaikg4ikCHv1744300104.png\" width=\"400\" /> Cardiac Troponin: (Option A) Preferred biochemical markers due to their sensitivity and specificity. Criteria for ACS: Requires rise and/or fall in biomarker values, with at least one value above the 99th percentile upper reference limit. Troponin T (cTnT) and Troponin I (cTnI ) increase significantly after STEMI. Can detect concentrations <1 ng/L in non-ischemic conditions. Troponin levels: Increase within 3-6 hours. Peak at around 36 hours. Remains elevated for 7-10 days after STEMI. Troponin should be measured at presentation and repeated at 1-3 hours (high-sensitivity assays) or 3-6 hours (conventional assays). Further troponin tests are advised beyond 3-6 hours if AMI remains a possibility or there is diagnostic uncertainty. Causes of elevated Serum Troponin other AMI Cardiorespiratory Causes Non-Cardiorespiratory Causes Pulmonary embolism Aortic dissection Acute pulmonary edema Tachyarrhythmias Myocarditis/Myopericarditis Cardiac trauma Cardiac surgery/ablation Prolonged hypotension Severe sepsis Severe burns Stroke Subarachnoid hemorrhage End-stage renal failure Cardiac troponin levels remain elevated for several days after an acute myocardial infarction (AMI), making them unreliable for detecting reinfarction. Creatine Phosphokinase (CK) and CK-MB: (Option B) CK rises within 4-8 hours. Peaks by 24 hours. Returns to normal within 48-72 hours. CK lacks specificity for STEMI since it can be elevated in skeletal muscle disease, trauma, or injections. CK-MB isoenzyme is more specific for the heart CK-MB elevated: Cardiac surgery Myocarditis Electrical cardioversion CK-MB/CK ratio >2.5 suggests a myocardial source, though it's not diagnostic. CK-MB levels normalize within 48 to 72 hours , so a subsequent rise can confirm reinfarction. Lactate Dehydrogenase (LDH): (Option C) Increase in the blood 6 to 12 hours after ACS. Peak within 24 to 72 hours. Normalize within 8 to 14 days. LDH is no longer used to diagnose myocardial infarction because it is not specific to cardiac myocytes. Heart-type Fatty Acid-Binding Protein (H-FABP): (Option D) Sensitivity of",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Cardiology-Ischemic Heart Disease"
    },
    {
      "q_no": 2,
      "question": "A 49-year-old woman comes at night with chest pain that started earlier that evening and has progressively worsened. She describes the pain as a burning sensation accompanied by a sour taste in her mouth, which began shortly after dinner. She has had similar experiences previously, but not as severe as now. Initial laboratory tests and an ECG show normal results. What is the most likely cause of this patient's chest pain?",
      "options": {
        "A": "Myocarditis",
        "B": "Pulonary embolism",
        "C": "Costochondritis",
        "D": "Gastroesophageal reflux disease"
      },
      "correct_answer": "D",
      "explanation": "Correct Answer: D) Gastroesophageal reflux disease Explanation: Given this patient's history of recurrent burning chest pain after meals accompanied by a sour taste, gastroesophageal reflux disease (GERD) is the most probable diagnosis, although it's important to remain vigilant for acute coronary syndrome (ACS) in any patient, particularly women and those with risk factors, as they may not always exhibit classic symptoms. Acute chest pain or chest discomfort is one of the leading reasons for a patient to visit the emergency department or the outpatient clinic. The evaluation and triaging of patients with chest pain can be simplified by considering three categories: Myocardial ischemia Other cardiopulmonary causes Non-cardiopulmonary causes Differential diagnoses of chest pain under cardiopulmonary and non-cardiopulmonary categories are as follows: Cardiopulmonary causes Non-cardiopulmonary causes Cardiac causes: Myocardial ischemia Pericarditis Gastrointestinal causes: Esophageal reflux Esophageal spasm Peptic ulcer Gallbladder disease Vascular causes: Acute aortic syndrome Pulmonary embolism Pulmonary hypertension Neuromuscular causes: Costochondritis Cervical disc disease Trauma or strain Herpes zoster Pulmonary causes: Pneumonia or pleuritis Spontaneous pneumothorax Psychological causes: Emotional and psychiatric conditions Acute Chest Pain\" data-author=\"NA\" data-hash=\"8692\" data-license=\"NA\" data-source=\"NA\" data-tags=\"April2025\" height=\"487\" src=\"https://image.prepladder.com/notes/MNtyZEBMkmieqQnZo13c1744299367.png\" width=\"487\" /> Myocarditis (Option A) is an inflammation of the heart muscle, often caused by a viral infection, such as the Coxsackie virus. It typically manifests as pleuritic chest pain and elevated cardiac enzymes and can result in heart failure due to impaired ventricular function. Pulmonary embolism (Option B) can lead to pleuritic chest pain , particularly if it results in pulmonary infarction. This condition should be considered in patients with risk factors such as the Virchow triad —blood stasis, endothelial injury, and a hypercoagulable state—along with signs of tachycardia and tachypnea. Costochondritis (Option C) occurs due to inflammation of the costal cartilage that links the ribs to the sternum. It is commonly characterized by chest pain that can be elicited through palpation. Reference: Harrison's principles of internal medicine, 21st Edition, Page: 101, 107.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Cardiology-Ischemic Heart Disease"
    },
    {
      "q_no": 3,
      "question": "A 70-year-old male presents with acute onset of severe dyspnea and shock 5 days after a STEMI. On examination, a loud pansystolic murmur is heard at the apex. Echocardiography reveals valvular dysfunction. What is the most likely cause of his condition?",
      "options": {
        "A": "Ventricular septal rupture",
        "B": "Papillary muscle rupture",
        "C": "Ventricular aneurysm",
        "D": "Ventricular rupture"
      },
      "correct_answer": "B",
      "explanation": "Correct Answer: B) Papillary muscle rupture Explanation: Papillary muscle rupture often occurs after a STEMI due to ischemia of the papillary muscles, leading to acute mitral valve insufficiency . The acute onset of severe dyspnea and shock, along with the loud pansystolic murmur, suggests significant regurgitation . Echocardiography revealing valvular dysfunction further supports the diagnosis, as ruptured papillary muscles result in severe mitral regurgitation . Complications of MI Hemodynamic Failure Pump Failure : Leading cause of in-hospital death after STEMI; severity correlates with infarct size. Signs : Pulmonary rales, S3/S4 gallop sounds, pulmonary congestion on chest x-ray. Elevated LV filling and pulmonary artery pressures due to diastolic/systolic dysfunction. Killip Classification: Class I : No pulmonary/venous congestion. Class II : Moderate heart failure (rales, S3 gallop, right-sided heart failure). Class III : Severe heart failure with pulmonary edema. Class IV : Cardiogenic shock with systolic BP <90 mmHg, peripheral vasoconstriction. Management: Use of balloon catheters and intra-arterial pressure monitoring. Diuresis for elevated LV pressure , volume expansion for lower LV pressure. Ventricular Aneurysm (Option C) Occurs in ~10% of MI patients, especially with persistent vessel occlusion. Clinical Signs : Paradoxical chest wall impulse, persistent ST elevation on ECG , and abnormal cardiac silhouette on chest X-ray. Diagnosis : Confirmed by echocardiography. Complications : Includes heart failure, ventricular arrhythmias, mural thrombus, and systemic embolism. Rupture Papillary Muscle Rupture (Option B) Presents with acute pulmonary edema and shock due to sudden severe mitral regurgitation . Often associated with a pansystolic murmur and 3rd heart sound . Confirmed with echocardiography; emergency valve replacement may be required. Ventricular Septum Rupture (Option A) Characterized by sudden hemodynamic deterioration and a loud pansystolic murmur radiating to the right sternal border. Causes left-to-right shunting through a ventricular septal defect, often leading to acute right heart failure. Confirmed by Doppler echocardiography and right heart catheterization. Emergency surgical repair is essential. Ventricular Rupture (Option D) Leads to cardiac tamponade and is usually fatal. incomplete ruptures may allow for emergency surgical repair. Embolism Thrombus can form on infarcted myocardium, leading to systemic embolism, which may cause stroke or ischemic limb. Venous thrombosis and pulmonary embolism are less common with prophylactic anticoagulants and early mobilization . Ventricular Remodelling Occurs after a transmural MI, with thinning and stretching of the infarcted area leading to ventricular dilatation and hypertrophy. Progressive dilatation increases wall stress, reducing efficiency and potentially causing heart failure. ACE inhibitors and mineralocorticoid receptor antagonists can reduce late ventricular remodeling and help prevent heart failure. Death Cause of death after MI According to time after MI 1st hour- Ventricular Fibrillation /Ventricular Tachycardia 1st day- Cardiogenic shock 3rd day- Cardiac rupture",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Cardiology-Ischemic Heart Disease"
    },
    {
      "q_no": 4,
      "question": "A 65-year-old male patient presents 6 weeks after experiencing an ST-elevation myocardial infarction (STEMI). He reports malaise, fever, and chest discomfort that worsens with deep breathing. On examination, a pericardial friction rub is heard. Laboratory tests reveal leukocytosis and an elevated ESR. What is the most appropriate initial treatment for this condition?",
      "options": {
        "A": "Glucocorticosteroids",
        "B": "Aspirin",
        "C": "NSAIDs",
        "D": "Antibiotics"
      },
      "correct_answer": "B",
      "explanation": "Correct Answer: B) Aspirin Explanation: The scenario indicates Dressler syndrome due to fever, malaise, and pericardial effusion occurring 6 weeks post-myocardial infarction, reflecting a delayed inflammatory response . Elevated inflammatory markers confirm this autoimmune reaction to myocardial injury. Aspirin is the initial treatment as it reduces inflammation and relieves symptoms without risking complications associated with NSAIDs or glucocorticosteroids, which can impair healing after an MI. Complications of MI Arrhythmias Arrhythmias are common soon after symptom onset, due to factors like autonomic imbalance and ischemia. Ventricular Premature Beats (VPBs): Beta-blockers are recommended to reduce ectopic activity and prevent ventricular fibrillation. Ventricular Tachycardia (VT) & Fibrillation (VF): VT and VF can occur within the first 24 hours without warning. Prophylactic lidocaine is no longer recommended as it does not reduce mortality and may increase the risk of bradycardia and asystole. Amiodarone is the preferred treatment for sustained VT , with electroversion for severe cases . VT or VF refractory to electroshock may respond to epinephrine or amiodarone . Accelerated Idioventricular Rhythm (AIVR): AIVR, also known as \"slow ventricular tachycardia,\" is a ventricular rhythm with a rate of 60–100 beats per minute. It commonly occurs transiently during fibrinolytic therapy, especially at the time of reperfusion . Benign and not indicative of more serious arrhythmias. Rarely progresses to classic VT. Requires no treatment with careful monitoring. Torsades de pointes may be due to electrolyte imbalances or drug toxicity . Investigate and address underlying causes in these cases. Sinus tachycardia is the most common , often secondary to other conditions (e.g., fever, heart failure). Treat underlying causes first. Sinus Bradycardia: Treated with atropine if it causes hemodynamic compromise. Persistent bradycardia may require pacing . Dressler Syndrome It is also known as post-myocardial infarction syndrome , it typically occurs 1 to 8 weeks after MI. Symptoms : Patients may experience malaise, fever, pericardial discomfort, leukocytosis, elevated ESR, and pericardial effusion. Pathology : Fibrinous pericarditis with polymorphonuclear leukocytes (PMNs) is often found at autopsy. Cause : Likely involves an immunopathologic process . Treatment : Aspirin (650 mg every 4 hours) is the main treatment. (Option B) Glucocorticosteroids and NSAIDs should be avoided within 4 weeks of STEMI due to risks of impaired infarct healing, ventricular rupture. (Option A & C) Reference: Harrison’s principles of internal medicine 21st edition Page 2063 Braunwald’s Heart disease a textbook of cardiovascular medicine 12th edition Page 704.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Cardiology-Ischemic Heart Disease"
    },
    {
      "q_no": 5,
      "question": "A 72-year-old female with a history of hypertension and hyperlipidemia presents with severe chest pain for 1 hour. Her ECG shows ST-elevation indicating a STEMI. She has a blood pressure of 180/110 mmHg and a history of active peptic ulcer disease. What is the most appropriate treatment option for this patient?",
      "options": {
        "A": "Streptokinase",
        "B": "Tissue plasminogen activator",
        "C": "Coronary artery bypass surgery",
        "D": "Percutaneous coronary intervention"
      },
      "correct_answer": "D",
      "explanation": "Correct Answer: D) Percutaneous coronary intervention Explanation: Percutaneous Coronary Intervention (PCI): (Option D) PCI (usually angioplasty and/or stenting) performed without preceding fibrinolysis in STEMI, also referred to as primary PCI. Effectiveness: Restores perfusion effectively when performed on an emergency basis in the first few hours of a myocardial infarction (MI). More effective than fibrinolysis in opening occluded coronary arteries. Advantages Over Fibrinolysis: Can be performed in patients with contraindications to fibrinolytic therapy. Diagnosis is uncertain. Cardiogenic shock is present. Increased bleeding risk exists. Symptoms have been present for 2–3 hours (clots are more mature and less responsive to fibrinolytic drugs). Fibrinolysis: Timing: Fibrinolytic therapy should be initiated within 30 minutes of presentation (door-to-needle time ≤ 30 min). Goal: Restore full coronary arterial patency. Fibrinolytic Agents: In MI- within 12 Hours In Stroke- within 4.5-6 Hours Tissue plasminogen activator (tPA). (Option B) Streptokinase. (Option A) Tenecteplase (TNK). Reteplase (rPA). These drugs act by promoting conversion of plasminogen to plasmin, which lyses fibrin thrombi. Absolute contraindications: History of cerebrovascular hemorrhage. Nonhemorrhagic stroke or cerebrovascular event in the past year. Marked hypertension (>180/110 mmHg) at presentation. Suspected aortic dissection. Active internal bleeding (excluding menses). Relative contraindications: Use of anticoagulants (INR >2). Recent (<2 weeks) invasive procedure or prolonged (>10 min) CPR. Bleeding diathesis Pregnancy Hemorrhagic ophthalmic conditions (e.g., hemorrhagic diabetic retinopathy) Active peptic ulcer disease. Streptokinase and Allergy Risk: Patients should not receive streptokinase if they have already received it within the preceding 5 days to 2 years due to the risk of allergic reactions. Allergic reactions to streptokinase occur in approximately 2% of patients who receive the drug. Coronary Artery Bypass Surgery: (Option C) Reserved for patients with coronary anatomy unsuitable for PCI but where revascularization is advisable due to: Extensive jeopardized myocardium. Recurrent ischemia.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Cardiology-Ischemic Heart Disease"
    },
    {
      "q_no": 6,
      "question": "A 60-year-old male with a history of hypertension and hyperlipidemia presents with chest pain lasting 45 minutes. His ECG confirms a STEMI, and he is stable with a blood pressure of 130/85 mmHg. Which of the following statements about his acute myocardial infarction management is true?",
      "options": {
        "A": "Beta blockers should be avoided in all patients with acute MI.",
        "B": "ACE inhibitors are contraindicated due to his blood pressure.",
        "C": "LMWH provides more reliable anticoagulation than UFH.",
        "D": "Glycoprotein IIb/IIIa inhibitors are not useful in acute MI."
      },
      "correct_answer": "C",
      "explanation": "Correct Answer: C) LMWH provides more reliable anticoagulation than UFH. Explanation: Low-Molecular-Weight Heparins (LMWH): (Option C) Advantages: Higher bioavailability Subcutaneous administration Reliable anticoagulation without monitoring Geater anti-Xa:IIa activity Enoxaparin reduces death/nonfatal reinfarction and urgent revascularization compared with unfractionated heparin (UFH), but has higher bleeding rates. Beta Blockers: (Option A) Effective in controlling pain and reducing risks of reinfarction and ventricular fibrillation. Metoprolol is commonly used, 5 mg IV every 2-5 minutes for a total of 3 doses. Start within 24 hours. Contraindication: Signs of heart failure Low-output state Risk of cardiogenic shock Second or third- degree heart block Active asthma ACE Inhibitors /Angiotensin Receptor Blockers: (Option C) Short-term benefit when prescribed to all hemodynamically stable STEMI patients. Those with systolic pressure >100 mmHg. Glycoprotein IIb/IIIa Inhibitors: (Option D) Drugs: Tirofiban, abciximab Block the final common pathway of platelet aggregation. Potent inhibitors of platelet-rich thrombus formation. These inhibitors help prevent thrombotic complications in patients undergoing PCI. Blood Glucose Control: Strict control in diabetic patients with STEMI reduces mortality. Serum Magnesium: Any deficits should be corrected to minimize arrhythmia risk. Reference: Harrison’s Principles of Internal Medicine, 21st Edition, Page 2057,2060,2061 Davidson’s Principles and Practice of Medicine, 24th Edition, Page 500",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Cardiology-Ischemic Heart Disease"
    },
    {
      "q_no": 7,
      "question": "A 65-year-old male presents with severe chest pain lasting 30 minutes. His ECG is taken and shown below. He has no known allergies, his blood pressure is 145/85 mmHg, and his oxygen saturation is 98%. Which of the following drugs should be avoided in this patient?",
      "options": {
        "A": "Administer morphine 2-4 mg IV for pain relief",
        "B": "Administer nifedipine 20 mg to relieve chest pain",
        "C": "Administer clopidogrel (300 mg loading dose) for platelet inhibition",
        "D": "Administer sublingual nitroglycerin (0.4 mg) to reduce myocardial oxygen demand"
      },
      "correct_answer": "B",
      "explanation": "Correct Answer: B) Administer nifedipine 20 mg to relieve chest pain Explanation: ECG shows ST elevations in leads II, III, aVF, V3, and V4 and ST segment depression in lead I. Calcium channel blockers, particularly short-acting dihydropyridines like nifedipine , should be avoided in the acute setting of STEMI as they can increase mortality risk. Immediate Goals: Control cardiac discomfort. Rapidly identify patients for reperfusion therapy. Proper triage of lower-risk patients. Avoid inappropriate discharge of STEMI patients. Overall Aim: Initiate percutaneous coronary intervention (PCI) within 120 minutes of first medical contact, including transfer to a PCI-capable facility if necessary. Aspirin: Chewing 160- 325 mg of aspirin rapidly inhibits platelet function. Follow with daily oral aspirin at 75-162 mg. Mechanism: Inhibits cyclooxygenase-1 in platelets, reducing thromboxane A2 levels. P2Y12 receptor antagonists are used with aspirin for up to 12 months. Clopidogrel (300mg, followed by 75 mg daily) with aspirin reduces death, reinfarction, and stroke risks in STEMI patients. (Option C) Newer drugs like ticagrelor (180 mg, followed by 90 mg twice daily) and prasugrel (60 mg , followed by 10 mg daily) are more effective than clopidogrel for ischemic complication prevention in STEMI patients undergoing PCI but have a higher bleeding risk. Oxygen Therapy: Supplemental oxygen is not beneficial or cost-effective for patients with normal oxygen saturation. For hypoxemic patients, administer oxygen via nasal prongs or face mask (2-4 L/min) for the first 6-12 hours after infarction. Reassess oxygen needs after the initial 6-12 hours. Sublingual Nitroglycerin (300-500µg) : (Option D) Up to three doses of 0.4 mg every 5 minutes. Relieve chest discomfort and reduce myocardial oxygen demand. Contraindication: Low systolic arterial pressure (<90 mmHg) RV infarction Recent use of phosphodiesterase-5 inhibitors Idiosyncratic fall of blood pressure (IV",
      "image": "https://raw.githubusercontent.com/tk22kalal/mcqimage/main/pxmedicine/Cardiology-Ischemic_Heart_Disease_Q7_q.jpg",
      "explanation_image": null,
      "chapter_heading": "Cardiology-Ischemic Heart Disease"
    },
    {
      "q_no": 8,
      "question": "A 55-year-old male presents to the emergency department with chest pain and is suspected of having an acute myocardial infarction (MI). Which of the following imaging techniques would provide the most accurate diagnosis of the MI?",
      "options": {
        "A": "Echocardiography",
        "B": "Gadolinium-enhanced cardiac MRI",
        "C": "Myocardial perfusion imaging with Tc-sestamibi",
        "D": "Radionuclide ventriculography"
      },
      "correct_answer": "B",
      "explanation": "contrast can detect infarction by showing a bright signal in the infarcted area , contrasting with dark areas of normal myocardium. Helps provide a detailed and accurate diagnosis of MI. Echocardiography: (Option A) Typically performed before hospital discharge. Detection of abnormal wall motion can indicate mechanical complications of MI or ischemic dysfunction. It helps assess ventricular function post-MI or other cardiac events. Useful in detecting significant complications such as: Cardiac rupture Ventricular septal defect (VSD) Mitral regurgitation Pericardial effusion Right ventricular (RV) infarction Ventricular aneurysm Left ventricular thrombus Myocardial perfusion imaging with Thallium or Tc-sestamibi: (Option C) These tracers are distributed in proportion to myocardial blood flow and concentrated by viable myocardium. Shows a defect (\"cold spot\") during the first few hours of a transmural infarction. Not specific for acute myocardial infarction, as it cannot distinguish between acute infarcts and chronic scars. Radionuclide Ventriculography: (Option D) Performed with Technetium (\"Tc\")-labeled red blood cells. Detects wall motion abnormalities and reduced ejection fraction in STEMI patients. Evaluate the hemodynamic effects of infarction and diagnose right ventricular (RV) infarction. Nonspecific, as various cardiac conditions other than MI can affect the results. Reference: Harrison’s Principles of Internal Medicine, 21st Edition, Page 108,2056 Davidson’s Principles and Practice of Medicine, 24th Edition, Page 498",
      "image": null,
      "explanation_image": "https://raw.githubusercontent.com/tk22kalal/mcqimage/main/pxmedicine/Cardiology-Ischemic_Heart_Disease_Q8_exp.png",
      "chapter_heading": "Cardiology-Ischemic Heart Disease"
    },
    {
      "q_no": 9,
      "question": "A 58-year-old male presents with chest pain, and an ECG reveals the following changes. Based on these findings, which coronary artery is most likely affected?",
      "options": {
        "A": "Left Circumflex Artery",
        "B": "Right Coronary Artery",
        "C": "Anterior Interventricular Artery",
        "D": "Posterior Descending Artery"
      },
      "correct_answer": "C",
      "explanation": "Correct Answer: C) Anterior Interventricular Artery Explanation: This patient’s ECG findings suggest an acute anterior wall myocardial infarction (MI), likely due to occlusion of the Anterior Interventricular Artery (Left Anterior Descending Artery - LAD). Extensive anterior wall STEMI is characterized by: ST elevation in leads V1–V6, I, and aVL. Q-wave formation in leads V1–V6 (sometimes in leads I and aVL). Reciprocal ST depression in leads II, III, and aVF. Infarct Localization based on ECG Infarct Location Affected Coronary Artery Leads Lateral Wall MI Left Circumflex Artery (LCx) (Option A) V5, V6, I, aVL Septal Wall MI Septal Branch of Left Anterior Descending Artery (LAD) V1, V2 Anterior Wall MI Left Anterior Descending Artery (LAD) V1-V4, I, aVL Extensive Anterior Wall MI Left Main Coronary Artery (LMCA) V1-V6, I, aVL Posterior Wall MI Posterior Descending Artery (PDA) (Option D) V1-V4 (ST depression), V7, V8, V9 (ST elevation) Inferior Wall MI Right Coronary Artery (RCA) (Option B) Leads II, III, aVF NSTEMI (Anterior Wall) Left Anterior Descending Artery (LAD) Often subtle changes in V1-V4 Reference: Harrison's principles of internal medicine, 21st Edition, Page: 1828,1829. Davidson's principles and practice of medicine, 24th Edition, Page: 449. https://www.cardiologymedjournal.com/articles/jccm-aid1082.php",
      "image": "https://raw.githubusercontent.com/tk22kalal/mcqimage/main/pxmedicine/Cardiology-Ischemic_Heart_Disease_Q9_q.png",
      "explanation_image": null,
      "chapter_heading": "Cardiology-Ischemic Heart Disease"
    },
    {
      "q_no": 10,
      "question": "A 65-year-old male patient with a history of coronary artery disease undergoes angiography, which reveals a thrombus in the right coronary artery (RCA). Based on this finding, which area of the heart is most likely to be affected by an infarct?",
      "options": {
        "A": "Anterior wall",
        "B": "Lateral wall",
        "C": "Inferior wall",
        "D": "Septal wall"
      },
      "correct_answer": "C",
      "explanation": "Correct Answer: C) Inferior wall Explanation: In a patient with a thrombus in the right coronary artery (RCA), the most likely area of the heart to be affected by an infarct is the inferior wall. Coronary Circulation: Origin: Root of the aorta, specifically from the Aortic Sinus, located just above the aortic valve. Main Coronary Arteries Left Coronary Artery (LCA) Branches: Left Circumflex Artery (LCX) Supply: Posterior part and lateral wall of the left ventricle. Branch: Obtuse Marginal Branch (supplies the lateral wall of the heart). Left Anterior Descending Artery (LAD) Supply: Anterior wall of the left ventricle. Interventricular Septum Branches: Diagonal Branch (supplies the anterior part of the left ventricle). Septal Branch (supplies the interventricular septum, which is important in septal myocardial infarction). Right Coronary Artery (RCA) Supply: Right ventricle and parts of the heart, including the inferior wall and posterior aspects. Branches: Posterior Descending Artery (PDA) (supplies Inferior part of the left ventricle and contributes to the posterior aspect of the septum) Right Marginal Artery (supplies the lateral wall of the right ventricle). Sinoatrial Artery (supplies the sinoatrial node). Coronary Artery Affected Location of Infarct Left Coronary Artery (LCA) Anterior Wall MI (most common) (Option A ruled out) Extensive Anterior Wall MI Left Circumflex Artery (LCX) Lateral Wall MI (Option B ruled",
      "image": "https://raw.githubusercontent.com/tk22kalal/mcqimage/main/pxmedicine/Cardiology-Ischemic_Heart_Disease_Q10_q.png",
      "explanation_image": null,
      "chapter_heading": "Cardiology-Ischemic Heart Disease"
    },
    {
      "q_no": 11,
      "question": "A 60-year-old male patient presents with acute chest pain radiating to his left arm. An ECG is performed, but upon review, the physician notices that Lead II has been incorrectly connected. To ensure accurate representation of the heart's electrical activity, the physician asks you to correct the lead placement. Which of the following connections should be made to achieve the correct placement for Lead II on the ECG? − ) − ) − ) to Left leg (+) − ) to Left leg (+)",
      "options": {
        "A": "Left arm (+) to Left arm (",
        "B": "Right arm (+) to Left arm (",
        "C": "Left arm (",
        "D": "Right arm ("
      },
      "correct_answer": "D",
      "explanation": "− ) to Left leg (+) Correct Answer: D) Right arm ( − ) to Left leg (+) Explanation: In an ECG, the correct configuration for Lead II involves placing the positive electrode on the Left Leg (LL) and the negative electrode on the Right Arm (RA). This configuration allows the ECG to capture the electrical activity of the heart as it flows from the right atrium to the left ventricle. 12-Lead ECG System for Cardiac Monitoring The 12-lead electrocardiogram (ECG) is a diagnostic tool used in cardiac monitoring, providing a comprehensive view of the heart's electrical activity. This system consists of 10 electrodes placed strategically around the body, producing 12 leads of the heart. Placement Chest Leads: V1: Placed in the 4th intercostal space (ICS) at the right parasternal line. V2: Positioned in the 4th ICS at the left parasternal line. V3: Located between V2 and V4. V4: Found in the 5th ICS at the left midclavicular line. V5: Set in the 5th ICS at the left anterior axillary line. V6: Placed in the 5th ICS at the left midaxillary line. Limb Leads: Einthoven's Triangle The concept of Einthoven's triangle is crucial for understanding lead placement in ECGs. It is an imaginary triangle formed by connecting the three limb electrodes (Right Arm, Left Arm, and Left Leg). The triangle represents the standard limb leads, which are as follows: Lead I: Left Arm (+) to Right Arm ( − ) Lead II: Left Leg (+) to Right Arm ( − ) Lead III: Left Leg (+) to Left Arm ( − ) Einthoven's Law: This principle states that the voltage in lead II equals the sum of the voltages in leads I and III (Lead II = Lead I + Lead III). Augmented Leads: Augmented leads are called so because they provide a higher voltage output—about 1.5 times higher than limb leads thus enhancing the detection of electrical signals. Lead aVL: Studies the left surface of the heart. Lead aVR: Studies the right surface, reading inversely to routine leads. Lead aVF: Acts like a camera positioned at the foot, scanning the diaphragm and right ventricle.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Cardiology-Ischemic Heart Disease"
    },
    {
      "q_no": 12,
      "question": "A 56-year-old male presents to the emergency department with chest pain radiating to his left shoulder, which did not relieve with rest. An ECG is conducted. What is the earliest sign of myocardial infarction that is most likely to be seen on the ECG?",
      "options": {
        "A": "Hyperacute T waves",
        "B": "Deep Q waves",
        "C": "Pardee sign",
        "D": "T Wave Inversions"
      },
      "correct_answer": "A",
      "explanation": "Correct Answer: A) Hyperacute T waves Explanation: Hyperacute T waves are often the earliest sign of myocardial infarction, characterized by broad, tall T waves. They appear before ST-segment elevation. ECG Findings in Myocardial Infarction (MI) Hyperacute T Waves Description: The earliest ECG change during an MI is the appearance of hyperacute T waves. These are characterized by their tall, peaked morphology, emerging shortly after the onset of myocardial ischemia. Normal T Wave Height: Limb leads: Typically less than 5 mm. Chest leads: Typically less than 10 mm. Clinical Significance: Hyperacute T waves can appear within seconds of coronary artery occlusion, signaling early myocardial injury. Their presence serves as an urgent prompt for further evaluation and intervention. ST Segment Elevation (Option C): Description: ST segment elevation is a key diagnostic marker for MI, particularly in ST-Elevation Myocardial Infarction (STEMI). Significant Elevation Criteria: Males: ST elevation greater than 2 mm. Females: ST elevation greater than 1.5 mm. Appearance: This elevation often resembles a Pardee sign or a tombstone pattern, defined by a convex upward shape of the ST segment. Clinical Significance: ST elevation indicates myocardial injury and typically occurs within minutes of coronary artery occlusion, suggesting a more severe injury compared to non-ST elevation myocardial infarction (NSTEMI). T Wave Inversions (Option D): Description: Following the initial phases of hyperacute T waves and ST elevation, T wave inversions may develop. These inversions are indicative of ongoing ischemia. Clinical Timeline: T wave inversions can occur within minutes to hours after the onset of ischemia, reflecting the progression of the myocardial injury. Deep Q Waves (Option B): Description: Over time, deep Q waves may appear on the ECG, signifying myocardial necrosis. Clinical Significance: The presence of these Q waves indicates cell death and can persist indefinitely, suggesting a prior MI. They are crucial for the long-term assessment of the patient’s cardiac history.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Cardiology-Ischemic Heart Disease"
    },
    {
      "q_no": 13,
      "question": "A 60-year-old male presents with a sudden onset of severe chest pain that radiates to his left arm. This pain started about 30 minutes ago while he was at rest. His medical history includes hypertension and hyperlipidemia. An ECG has been performed and cardiac biomarkers are significantly elevated. What is the most likely cause of his presentation?",
      "options": {
        "A": "Coronary artery spasm",
        "B": "Coronary artery embolism",
        "C": "Spontaneous coronary artery dissection",
        "D": "Plaque rupture"
      },
      "correct_answer": "D",
      "explanation": "Correct Answer: D) Plaque rupture Explanation: The 12-lead ECG reveals notable ST-segment elevation in leads II, III, and aVF, accompanied by reciprocal ST-segment depression in leads I and aVL, indicating an inferior wall ST-segment elevation myocardial infarction (STEMI). The primary underlying cause of this STEMI is often the rupture of an atherosclerotic plaque, which results in thrombus formation and subsequent myocardial ischemia. ST-Elevation Myocardial Infarction (STEMI) ST-Elevation Myocardial Infarction (STEMI) is a type of heart attack characterized by the prolonged obstruction of blood supply to a part of the heart muscle, leading to tissue damage or necrosis. It is identified by significant ST-segment elevation on an electrocardiogram (ECG). Pathophysiology Risk Factors for STEMI Modifiable Risk Factors: Hypertension Hyperlipidemia Smoking Diabetes Mellitus Sedentary Lifestyle Obesity Non-Modifiable Risk Factors: Age Gender Family History Presentation Chest Pain: Often described as a heavy, crushing, or squeezing sensation that may radiate to the arms, neck, jaw, or back. Shortness of Breath Diaphoresis: Sweating is common and may be profuse. Nausea and Vomiting Anxiety ECG Findings ST-Segment Elevation: Elevated ST segments in at least two contiguous leads. T-Wave Changes: Inverted or peaked T waves may be seen in the early stages. Pathological Q Waves: May develop within hours to days, indicating myocardial necrosis. Coronary artery spasm (Prinzmetal’s angina) (Option A): This causes transient ST-segment elevation due to vasospasm but does not typically lead to the same pattern of ischemia or cardiac marker elevation seen in this patient. Coronary artery embolism (Option B): Although a possible cause of myocardial infarction, it is much rarer compared to plaque rupture. Coronary emboli",
      "image": "https://raw.githubusercontent.com/tk22kalal/mcqimage/main/pxmedicine/Cardiology-Ischemic_Heart_Disease_Q13_q.jpg",
      "explanation_image": null,
      "chapter_heading": "Cardiology-Ischemic Heart Disease"
    },
    {
      "q_no": 14,
      "question": "A 72-year-old man present with chest pain and shortness of breath. He has a history of coronary artery disease and underwent a percutaneous coronary intervention (PCI) two days ago. An ECG shows ST-segment depression, and initial cTn values are found to be normal. Later, the cTn levels rise to five times the 99th percentile of the upper limit. What is the diagnosis here?",
      "options": {
        "A": "Type 1",
        "B": "Type 2",
        "C": "Type 5",
        "D": "Type 4a"
      },
      "correct_answer": "D",
      "explanation": "Correct Answer: D) Type 4a Explanation: The clinical scenario here describes a patient with a history of PCI done who has now developed symptoms of MI with cardiac troponin levels increased to 5 times the normal value, which points to Type 4a MI as the diagnosis. The ST wave depression suggests ischemia of the affected myocardium initially. The fourth universal definition of myocardial infarction (MI) includes many changes and new concepts to improve clinical practice and differentiate between myocardial infarction and injury. Universal definition of MI Myocardial injury is when there is evidence of elevated cardiac troponin (cTn) levels with at least one value above the 99th percentile upper reference limit (URL). Myocardial injury can be considered acute if the cTn values rise and/or fall. Types of MI Type 1 MI (Option A) It is defined when there is a rise and/or fall of cardiac troponin (cTn) with at least one value above the 99th percentile of the upper limit. With at least one of the following: Symptoms of acute myocardial injury . New ischemic ECG changes. Development of pathological Q waves . Imaging evidence of new loss of viable myocardium or new regional wall motion abnormality consistent with ischemia. Identification of a coronary thrombus by angiography, intracoronary imaging, or autopsy. Type 2 MI (Option B) This does not include the identification of coronary thrombus. Develops secondary to another illness or process. Possible mechanisms include: Fixed coronary atherosclerosis Coronary spasm Coronary embolism Coronary artery dissection Sustained tachyarrhythmia Severe bradyarrhythmia Severe hypertension Respiratory failure Shock Severe anemia or hypotension Type 3 MI Very rare, constituting 3–4% of all MIs. Defined as death from probable cardiac causes. Distinction from non-cardiac causes of sudden death is important. Autopsy findings of fresh or recent thrombus in the infarct-related artery confirm Type 1 MI instead of Type 3 MI. Type 4a MI related to percutaneous coronary intervention (PCI) Requires a fivefold increase in cTn values if initial values are normal. If initial cTn values are above the 99th percentile URL, a 20% rise is needed , with final values exceeding five times the 99th percentile. Type 4b MI This is associated with a stent thrombosis . Type 4c MI Associated with focal or diffuse restenosis after PCI . Defined by a rise and/or fall of cTn values above the 99th percentile URL. Diagnosis aligns with the criteria for Type 1 MI. Type 5 MI related to coronary artery bypass grafting (CABG) (Option C) Requires a tenfold increase in cTn values if initial values are normal. If initial cTn values are above the 99th percentile URL, a 20% rise is needed, with final values exceeding ten times the 99th percentile. Reference: Harrison's principles of internal medicine, 21st Edition, Page: 2057. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078947/",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Cardiology-Ischemic Heart Disease"
    },
    {
      "q_no": 15,
      "question": "Which of the following vessels is at the greatest risk of atherosclerosis, arranged from highest to lowest?",
      "options": {
        "A": "Popliteal arteries > Coronary arteries > Circle of Willis > Abdominal aorta",
        "B": "Coronary arteries > Abdominal aorta > Circle of Willis > Popliteal arteries",
        "C": "Abdominal aorta > Coronary arteries > Popliteal arteries > Circle of Willis",
        "D": "Coronary arteries > Circle of Willis > Abdominal aorta > Popliteal arteries"
      },
      "correct_answer": "C",
      "explanation": "Correct Answer: C) Abdominal aorta > Coronary arteries > Popliteal arteries > Circle of Willis accumulation of lipid-laden plaques, leading to reduced blood flow and potential tissue damage. This process is the primary cause of coronary artery disease (CAD), which may lead to myocardial infarction (MI) due to plaque rupture followed by clot formation. Risk Factors Obesity and Diabetes Hypothyroidism, Systemic Lupus Erythematosus (SLE), and Rheumatoid Arthritis Arteries Involved in Atherosclerosis 1. Abdominal Aorta: Atherosclerosis in the abdominal aorta can lead to the formation of an abdominal aortic aneurysm (AAA) 2. Coronary Arteries: A blockage of 70% or more in the coronary arteries results in chronic stable angina, characterized by chest pain during exertion. If a plaque fissure or rupture occurs, it can cause an acute coronary syndrome (ACS), such as: ST-Elevation Myocardial Infarction (STEMI) - Complete occlusion- Fibrin rich thrombi- Treated with antifibrinolytics Non-ST Elevation Myocardial Infarction (NSTEMI) and Unstable Angina - Incomplete Occlusion- platelet rich thrombi- treated with antiplatelet drugs. 3. Popliteal Arteries : Atherosclerosis in these arteries leads to peripheral artery disease (PAD), causing intermittent claudication 4. Circle of Willis: Atherosclerotic plaques in the cerebral arteries can result in transient ischemic attacks (TIA) or strokes. Order of prevalence Abdominal aorta > Coronary arteries > Popliteal arteries > Circle of Willis Markers of Atherosclerosis High-Sensitivity C-Reactive Protein: Elevated levels of hsCRP are a strong predictor of future coronary events. It is considered the best single test to detect coronary artery disease (CAD). Elevated Total Cholesterol: High total cholesterol, particularly when the total cholesterol to HDL ratio exceeds 3.5-5.5. High Lipoprotein (a)-Similar to LDL and plasminogen- So atherogenic and Apolipoprotein B",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Cardiology-Ischemic Heart Disease"
    },
    {
      "q_no": 16,
      "question": "A 58-year-old man presents with chest pain similar to episodes he experienced in the past. He has a history of hypertension and hyperlipidemia. The ECG shows ST-segment depression <0.5mm, and his cardiac troponin levels are elevated. Using the TIMI risk scoring system, what is the most appropriate next step in managing this patient's condition?",
      "options": {
        "A": "Immediate coronary artery bypass grafting (CABG)",
        "B": "Discharge with a referral for outpatient stress testing",
        "C": "Initiate high-dose atorvastatin and schedule for follow-up in one month",
        "D": "Administer sublingual nitroglycerin and start intravenous beta-blockers"
      },
      "correct_answer": "D",
      "explanation": "Correct Answer: D) Administer sublingual nitroglycerin and start intravenous beta-blockers score, he has two risk factors (past history of angina and raised cardiac markers) giving him a score of 8% which shows a low risk and can be treated with sublingual nitroglycerin and start intravenous beta-blockers . The Diagnosis of NSTEMI is based on the history and clinical findings, such as age, ECG changes, and circulating troponins. Based on the risk factors, a scoring system known as the Thrombolysis in Myocardial Infarction (TIMI) risk scoring system is used and is as follows: Risk factors Age ≥ 65 years Known coronary artery disease ST deviation >0.5mm on presenting ECG Raised cardiac markers ≥ 2 original episodes in the prior 24 hours Prior angina ≥ 3 CAD risk factors Number of risk factors Incidence of adverse cardiac events (%) 0/1 5 2 8 3 13 4 20 5 26 6/7 41 A higher TIMI score indicates an increased likelihood of adverse cardiac events and mortality risk. Scores of 0 to 2- low risk. Scores ranging from 3 to 5- intermediate risk. Scores of 6 or 7- high risk. Management of NSTEMI-ACS Management of NSTEMI involves evaluating patients with a low likelihood of ischemia in emergency settings, continuous ECG monitoring, stress testing, and serum troponin assessments, while those who meet criteria for NSTE-ACS are admitted for further monitoring and medical treatment aimed at stabilizing their condition and preventing future events. Medical management Anti-ischemic therapy: Sublingual glyceryl trinitrate/nitroglycerin: DOC for unstable angina For ischemic discomfort IV beta-blockers (Atenolol, Metoprolol): They reduce the oxygen demand of the myocardium They relieve pain, reduce arrhythmias, and reduce short-term mortality Verapamil and diltiazem: Given if symptoms are not relieved by full dose beta blockers and nitrates They decrease the heart rate IV morphine sulfate or diamorphine: For analgesia Antiemetics like metoclopramide (For symptomatic relief) Nifedipine or amlodipine (If chest discomfort persists) Atorvastatin and other HMG-CoA reductase inhibitors: Reduces occurrence of MI and recurrences of acute coronary syndrome Ezetimibe or alirocumab, evolocumab: Given if unresponsive to full dose statins They reduce LDL cholesterol and prevent further cardiovascular events Antithrombotic therapy: Antiplatelet drugs: Cyclooxygenase inhibitor: aspirin Platelet P2Y12 receptor inhibitor: clopidogrel Anticoagulants: Unfractionated heparin. Low molecular heparin: enoxaparin. Direct thrombin inhibitor: bivalirudin. Synthetic factor Xa inhibitor: fondaparinux. Invasive management Done if the medical management fails and symptoms do not improve. (Option A) Coronary arteriography must be done within 48 hours of presentation. Coronary revascularization includes PCI (percutaneous coronary intervention) or coronary artery bypass grafting (CABG) . Discharge with a referral for outpatient stress testing (Option B) is only done after stabilizing the patient and is inappropriate for an acute",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Cardiology-Ischemic Heart Disease"
    },
    {
      "q_no": 17,
      "question": "A 59-year-old woman with type 2 diabetes presents to your office with chest discomfort at rest, jaw pain, and nausea. On examination, she appears anxious, with cool, pale skin. The symptoms occurred suddenly 2 hours ago and are getting worse. She has a 20-pack-year smoking history. An ECG shows multiple T wave inversions and ST depressions in contiguous leads, and lab reports show raised Trop-I. Which of the following is the most likely diagnosis?",
      "options": {
        "A": "Stable angina",
        "B": "Unstable angina",
        "C": "Non-ST elevation MI",
        "D": "ST elevation MI"
      },
      "correct_answer": "C",
      "explanation": "Correct Answer: C) Non-ST elevation MI Explanation: The scenario here points to non-ST elevation MI, which is diagnosed by raised serum troponin levels, ECG changes of T-wave inversion, and clinical symptoms of chest pain . It involves myocardial necrosis, which is absent in unstable angina. Acute coronary syndrome (ACS) encompasses three subgroups: ST-segment elevation myocardial infarction (STEMI) Non-ST-segment elevation myocardial infarction (NSTEMI) Unstable angina. ACS is associated with considerable morbidity and mortality, making timely diagnosis and effective treatment crucial. NSTEMI is characterized by the presence of positive cardiac biomarkers, distinguishing it from unstable angina. Clinical features of NSTEMI: The diagnosis is based on a combination of history, clinical findings (age, ECG changes), and circulating troponin levels. Chest discomfort: Occurs at rest or with minimal exertion, lasting more than 10 minutes. Recent onset within the past 2 weeks. Has a crescendo pattern that is, more severe, prolonged, or frequent than previous episodes. Diagnosis is confirmed when a patient with the above features (without ST-segment elevations on ECG) shows evidence of myocardial necrosis via elevated troponin levels, excluding other explanations. Location of discomfort: typically substernal, radiating to: Left arm Left shoulder Neck and jaw Anginal equivalents may present instead of typical chest discomfort, including: Dyspnea Epigastric discomfort Nausea Weakness These anginal equivalents are more common in: Women Elderly patients Individuals with diabetes mellitus Physical examination findings: May resemble stable angina and could be unremarkable. In cases of significant myocardial ischemia or large NSTEMI, signs may include: Diaphoresis Pale, cool skin Sinus tachycardia Third and/or fourth heart sounds Basilar rales Hypotension Workup for NSTEMI: Electrocardiogram (ECG) : New ST-segment depression occurs in approximately one-third of patients with NSTE-ACS, which may be transient but can last several days after NSTEMI. T-wave changes are common but less specific for ischemia unless they present as new and deep inversions ( ≥ 0.3 mV). Cardiac Biomarkers : Patients with NSTEMI exhibit elevated levels of cardiac troponin ( cTn) I or T (cTnI or cTnT), which are sensitive and relatively specific markers for myocardial necrosis. Elevated cTn levels with dynamic changes help differentiate NSTEMI from unstable angina (UA). The plasma concentration of cTn typically rises within 12–24 hours after symptom onset and gradually decreases thereafter. It differentiates myocardial injury ( cTn levels >99th percentile without clear acute ischemia) from myocardial necrosis , as the former can arise from various noncardiac and cardiac conditions. Imaging : Coronary computed tomographic angiography (CCTA) may enhance the accuracy and speed of diagnostic evaluation by identifying or",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Cardiology-Ischemic Heart Disease"
    },
    {
      "q_no": 18,
      "question": "A 55-year-old male presents with chest pain. ECG is given below. Considering this presentation, which of the following conditions could be responsible for the observed ST elevations? Hyperkalemia Variant Angina Digoxin (Therapeutic doses) Left Ventricular Hypertrophy (LVH) Chronic Stable Angina",
      "options": {
        "A": "1 and 3",
        "B": "1, 2, and 4",
        "C": "2, 3, and 5",
        "D": "All are correct"
      },
      "correct_answer": "B",
      "explanation": "Correct Answer: B) 1, 2, and 4 Explanation: Conditions for ST elevation- Due to systolic current injury and ST depression ST Elevation ST Depression Elevation - Answer\" data-author=\"NA\" data-hash=\"8685\" data-license=\"NA\" data-source=\"NA\" data-tags=\"April2025\" height=\"384\" src=\"https://image.prepladder.com/notes/3D6CmFhfrh6BiNcm4ZJ51744299120.png\" width=\"384\" /> Acute Myocardial Infarction (STEMI) Prinzmetal Angina (Option 2) Left Bundle Branch Block (LBBB) Brugada syndrome Left Ventricular Hypertrophy (LVH) (Option 4) Pericarditis Benign early repolarization Takotsubo Cardiomyopathy Aortic Dissection Hyperkalemia (Option 1) Non-ST-Elevation Myocardial Infarction (NSTEMI) Digoxin (Therapeutic doses) (Option 3 ruled out) Chronic Stable Angina (Option 5 ruled out) Chronic Obstructive Pulmonary Disease (COPD) Hypokalemia",
      "image": "https://raw.githubusercontent.com/tk22kalal/mcqimage/main/pxmedicine/Cardiology-Ischemic_Heart_Disease_Q18_q.jpg",
      "explanation_image": null,
      "chapter_heading": "Cardiology-Ischemic Heart Disease"
    },
    {
      "q_no": 19,
      "question": "A 65-year-old man presents to the emergency department with episodes of chest pain occurring at rest, particularly during the night. His symptoms are often triggered by emotional stress and are relieved by nitroglycerin. An ECG was performed and is given below. There is no elevation of cardiac markers. Which of the following is the most likely diagnosis?",
      "options": {
        "A": "Stable angina",
        "B": "Unstable angina",
        "C": "Prinzmetal angina",
        "D": "Myocardial infarction"
      },
      "correct_answer": "C",
      "explanation": "Correct Answer: C) Prinzmetal angina Explanation: Based on the given scenario, the diagnosis is consistent with Prinzmetal angina, which is characterized by episodes of chest pain at rest, often relieved by nitroglycerin, and associated with transient ST-segment elevations on ECG. It is caused by coronary artery spasm rather than obstructive coronary artery disease, and cardiac markers remain normal during these episodes. Prinzmetal angina: Prinzmetal angina, also known as variant angina, is a specific form of angina pectoris characterized by episodes of chest pain resulting from coronary artery spasm. Unlike typical angina, which is usually triggered by exertion, Prinzmetal angina can occur at rest. Pathophysiology At the molecular level, the mechanism involves the conversion of the amino acid arginine into nitric oxide (NO), a potent vasodilator. This conversion is facilitated by the enzyme nitric oxide synthase 3 (NOS3), predominantly located in the endothelial cells of the coronary arteries. Consequently, NO production significantly decreases, leading to inadequate vasodilation of the coronary arteries. This impaired response may result in arterial constriction rather than relaxation, causing episodes of coronary artery spasm. Clinical Presentation Demographics: Typically affects middle-aged individuals; for instance, a 60-year-old female may experience recurrent episodes. Symptoms: Characterized by diffuse chest pain, often described as squeezing or pressure-like. These episodes may occur spontaneously, especially at rest, and can be exacerbated by emotional stress or cold exposure. Many patients may also have episodes of silent ischemia. Diurnal Variation: Symptoms may vary based on the time of day. Seasonal Variation: Patients often report increased frequency of symptoms during winter compared to summer, potentially",
      "image": "https://raw.githubusercontent.com/tk22kalal/mcqimage/main/pxmedicine/Cardiology-Ischemic_Heart_Disease_Q19_q.png",
      "explanation_image": null,
      "chapter_heading": "Cardiology-Ischemic Heart Disease"
    },
    {
      "q_no": 20,
      "question": "A 62-year-old male presents to the emergency department with episodes of chest pain at rest that lasts for about 15 minutes and shortness of breath. The pain is central and radiates to the left arm and jaw. His medical history includes hypertension and hyperlipidemia. Investigations show normal enzyme levels. Which of the following is the most appropriate initial management for this patient's condition?",
      "options": {
        "A": "Immediate coronary revascularization",
        "B": "Administration of sublingual nitroglycerin",
        "C": "Initiation of atorvastatin therapy",
        "D": "Administration of oral beta-blockers"
      },
      "correct_answer": "B",
      "explanation": "Correct Answer: B) Administration of sublingual nitroglycerin Explanation: The clinical scenario points to the diagnosis of unstable angina for which the most appropriate initial management is the administration of nitroglycerin, which is the drug of choice for this condition. It causes vasodilation, thus improving the chest discomfort and relieving symptoms. Management of unstable angina: The primary focus of treatment is to enhance coronary artery perfusion through various methods: Aspirin Administered for its antiplatelet effects , typically at a dose of 162-325 mg orally or 300 mg rectally if the patient cannot swallow. Aspirin should be given within 30 minutes of presentation. Nitroglycerin (DOC for unstable angina) Available in several forms (intravenous, sublingual, transdermal, oral), it promotes vasodilation of the coronary arteries, improving blood flow and lowering blood pressure . This action reduces the heart's workload and energy demands. Clopidogrel An alternative for patients intolerant to aspirin. While prasugrel is more effective, it carries a higher bleeding risk. Ticagrelor has also been approved for use alongside aspirin to lower the incidence of thrombotic cardiac events. Supplemental Oxygen Administered via nasal cannula to maintain adequate oxygen saturation. These three interventions are critical for the evaluation and management of unstable angina. Continuous monitoring is essential, especially if pain persists, as these patients are at an increased risk for myocardial infarction. Other",
      "image": "https://raw.githubusercontent.com/tk22kalal/mcqimage/main/pxmedicine/Cardiology-Ischemic_Heart_Disease_Q20_q.jpg",
      "explanation_image": null,
      "chapter_heading": "Cardiology-Ischemic Heart Disease"
    },
    {
      "q_no": 21,
      "question": "A 65-year-old woman presents to the emergency department with a 30-minute episode of chest discomfort that occurred while she was watching television. She describes the pain as a tightness in his chest, radiating to her left arm. She has a history of diabetes and high cholesterol. An ECG reveals inverted T-waves. Which of the following investigations is considered the most crucial next step in evaluating her condition?",
      "options": {
        "A": "Troponin test",
        "B": "Cardiac catheterization",
        "C": "Cardiac stress test",
        "D": "Myocardial perfusion imaging"
      },
      "correct_answer": "A",
      "explanation": "Correct Answer: A) Troponin test Explanation: The scenario here is of unstable angina with T-wave inversion, which is made with the clinical features, but, to rule out acute coronary syndrome (unstable angina with non-ST elevated myocardial infarction), a troponin test is the next step of investigation, and the rest are done later. Unstable angina: Unstable angina is defined as new onset or rapidly worsening angina, angina on minimal exertion, or angina at rest in the absence of myocardial damage. Triggering factors of unstable angina: Plaque fissures Platelet-rich thrombus Protein C/S/AT3 deficiencies (part of anticoagulant system) Vasospasm Pathophysiology: Risk factors include age ≥ 65 years, history of smoking, diabetes, high cholesterol, obesity, anemia, etc. Unstable angina is caused due to blood flow obstacles leading to hypoperfusion of the myocardium. The factors that cause this obstruction/block are: Intraluminal plaque formation Intraluminal thrombosis Vasospasm Elevated BP The coronary arteries divide into smaller arteries which when blocked, cause deprivation of blood flow and oxygen to the myocardium. This is usually caused by broken parts of plaque from atherosclerosis or a thrombus forming an embolus in the artery, or a combination of any of the above causes leading to an obstruction. Thrombolysis is absolutely contraindicated, as it will further break down these small fragments and worsen the condition. The “ vulnerable plaques ” in atherosclerosis show eccentric stenosis with scalloped or overhanging edges and a narrow neck. These are made of a lipid core surrounded by a thin fibrous cap. Clinical features: Chest pain: Pressure-like, tightness , burning, sharp pain. Shortness of breath. Pain at rest (>10 minutes) or with minimal exertion. Pain radiating to the jaw, left arm, and/or left shoulder. Constitutional symptoms like nausea, vomiting, diaphoresis, dizziness, and palpitations. Pain may not completely resolve with nitroglycerine and aspirin. Investigations ECG is the first and must investigation in this case, and it shows: Hyperacute T-waves Flat T-waves Inverted T-waves (25% cases) ST depression (25% cases) Normal ST wave (50%) Most commonly, sinus rhythm is seen in unstable angina Blood investigations: CBC, platelet count, metabolic profile Troponin test for infarction (normal or slightly elevated) Coagulation studies Chest X-ray to rule out other conditions. Cardiac stress tests: (Option C) Walking treadmill stress test Stress echocardiogram Myocardial perfusion imaging (Option D) Cardiac CT/MRI Cardiac catheterization ( Gold standard ) (Option B)",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Cardiology-Ischemic Heart Disease"
    },
    {
      "q_no": 22,
      "question": "What is the revascularization procedure of choice for triple vessel disease and left main coronary artery disease, respectively?",
      "options": {
        "A": "CABG; PCI with stenting",
        "B": "CABG for both",
        "C": "PCI with stenting; CABG",
        "D": "PCI with stenting; PCI with stenting"
      },
      "correct_answer": "B",
      "explanation": "Correct Answer: B) CABG for both Explanation: CABG is preferred over PCI with drug-eluting stenting (DES) for Multivessel disease and Left main coronary artery involvement. CABG remains the standard of care as it results in significantly lower rates of death, MI, and repeat revascularization. Condition Preferred Treatment Single or two-vessel disease (non-proximal LAD, non-left main) High surgical risk (comorbidities) Contraindication to surgery Elderly patients (>80 years or frailty) PCI (Percutaneous Coronary Intervention) Multivessel disease Proximal LAD involvement Left main coronary artery involvement In-stent restenosis (with DES in major arteries) CABG (Coronary Artery Bypass Grafting) Triple vessel disease management : In stable CAD, the main goal of revascularization is to manage symptoms, improve quality of life, and increase exercise tolerance. CABG is the preferred treatment. Patients with multivessel disease require optimal medical therapy and lifestyle changes like quitting tobacco, limiting alcohol, exercising, reducing salt, and losing weight. Aspirin is used for secondary prevention, while beta-blockers and calcium channel blockers help with angina. Statins effectively manage cholesterol and reduce mortality. Managing diabetes and controlling hypertension are also key modifiable risk factors. Double vessel disease: Single site obstruction: PCI with stenting Multiple site obstruction: CABG Single vessel disease: PCI with drug-eluting stenting is preferred. The coating over the stent is Everolimus / Sirolimus (Immunomodulator). Reference: https://pubmed.ncbi.nlm.nih.gov/25085960/ https://www.ahajournals.org/doi/full/10.1161/circulationaha.113.004382 https://www.ncbi.nlm.nih.gov/books/NBK557895/",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Cardiology-Ischemic Heart Disease"
    },
    {
      "q_no": 23,
      "question": "A 65-year-old male with chronic stable angina presents with worsening chest pain during routine activities. His current medications include aspirin, clopidogrel, metoprolol, and atorvastatin, but his symptoms persist. ECG shows ST-segment depression in V5-V6, and coronary angiography reveals 80% stenosis of the left anterior descending (LAD) artery. What is the most appropriate intervention?",
      "options": {
        "A": "Increase the dose of beta-blockers",
        "B": "Add ranolazine to medical therapy",
        "C": "Percutaneous coronary intervention (PCI) with drug-eluting stent (DES)",
        "D": "Refer for coronary artery bypass grafting (CABG)"
      },
      "correct_answer": "C",
      "explanation": "Correct answer: C) Percutaneous coronary intervention (PCI) with drug-eluting stent (DES) optimal medical therapy. PCI with a drug-eluting stent (DES) is the most appropriate intervention in this scenario, as it restores blood flow and relieves symptoms. DES is preferred due to its lower risk of restenosis compared to bare-metal stents. Medical management Medication Class Function/Mechanism Indications Side Effects/ Contraindication Nitrates Sublingual nitroglycerin (0.4 or 0.6 mg) Long-acting forms (oral, transdermal) Systemic venodilation Reduces LV end-diastolic volume and pressure Releases nitric oxide (NO) to relax vascular smooth muscle Angina relief Preemptive use before activities Improves exercise tolerance Tolerance development Headaches, dizziness Beta-Blocker (Option A) Reduces heart rate, arterial pressure, and myocardial contractility Improves survival post-MI Angina relief Reduces mortality and reinfarction rates Asthma AV conduction disturbances Severe bradycardia Calcium Channel Blockers Coronary vasodilators Reduces myocardial oxygen demand and arterial pressure Dihydropyridines (e.g., amlodipine) and non-dihydropyridines (e.g., verapamil) Angina treatment when beta blockers are ineffective Variant angina Bradyarrhythmias May aggravate LV failure Antiplatelet Drugs Aspirin : inhibits platelet activation Clopidogrel 75mg : blocks platelet aggregation Reduces coronary events in high-risk populations Stent placement Risk of bleeding Gastrointestinal issues, allergies Other Therapies : Ranolazine : Inhibits late sodium current , minimizing Na and Ca overload in ischemic myocytes. (Option B) SGLT2 Inhibitors : Provide cardiovascular and renal protection , promoting weight loss and reducing plasma volume; beneficial in IHD patients. Nicorandil : Opens ATP-sensitive potassium channels. Ivabradine : Reduces heart rate in patients with IHD and LV dysfunction. Percutaneous Coronary Intervention (PCI) (Option C) PCI involves balloon dilatation and stenting for symptomatic IHD with suitable stenoses in epicardial coronary arteries. Indications : Symptom-limiting angina despite optimal medical therapy. Evidence of ischemia during stress tests. Post-PCI Management : Aspirin is administered indefinitely, and P2Y12 antagonists for 1-3 months. Current-generation drug-eluting stents reduce restenosis but require prolonged dual antiplatelet therapy (DAPT). Coronary Artery Bypass Grafting (CABG) (Option D) Involves bypassing obstructive lesions using internal mammary arteries , radial arteries , or saphenous veins . Indications : Safe with low mortality in patients without serious comorbidities and normal LV function. Effective for patients with left main coronary artery stenosis , multivessel disease , or impaired LV function . Outcomes : Angina relief in ~90% of patients after complete revascularization. Long-term survival benefits in specific populations, particularly those with diabetes or impaired LV function .",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Cardiology-Ischemic Heart Disease"
    },
    {
      "q_no": 24,
      "question": "A 60-year-old man with a history of CAD presents with recurrent syncope. He has no obvious structural heart disease on echocardiography. Considering his intermediate to high risk for CAD, which imaging modality would be most appropriate for further evaluation?",
      "options": {
        "A": "Myocardial Perfusion Imaging with Thallium-201 (Tl-201)",
        "B": "Stress Echocardiography",
        "C": "Multigated Acquisition (MUGA) Scanning",
        "D": "PET"
      },
      "correct_answer": "A",
      "explanation": "Correct Answer: A) Myocardial Perfusion Imaging with Thallium-201 (Tl-201) Explanation: Myocardial perfusion imaging is ideal for evaluating ischemia in patients with intermediate to high CAD risk, like this patient with a history of CAD and syncope . Thallium-201 imaging effectively detects areas of reduced blood flow , helping identify underlying ischemic disease. It's preferred when structural heart disease has been ruled out, as in this case, where echocardiography showed no abnormalities. Myocardial perfusion imaging Done with Technetium-99m (Tc-99m) or Thallium-201 (Tl-201). Indications : CAD Detection Heart Failure Assessment Ventricular Tachycardia : Investigating high-risk patients for CAD. Syncope Evaluation : Assessing syncope in those at intermediate to high risk for CAD. Indeterminate Previous Results Angina Symptoms Post-Revascularization Assessment : Risk assessment for patients with ischemic symptoms, incomplete revascularization in asymptomatic individuals, or those more than 5 years post-CABG. Myocardial Viability : Determining revascularization candidacy based on myocardial viability. Stress Echocardiography (Option B ruled out) Used in patients who cannot exercise or have resting ECG abnormalities, preferred for evaluating LV function and ischemia. Image quality can be affected by obesity and COPD. Technician-dependent. Positron Emission Tomography (PET) (Option D ruled out) Functionality assesses myocardial viability through glucose metabolism. Advantages : High sensitivity and contrast resolution for detecting ischemia. High predictive value for future cardiac events. Enhanced detection of multi-vessel disease and active atherosclerotic plaques with new radiotracers. Potential to avoid unnecessary interventions, despite high costs. Multigated Acquisition (MUGA) Scanning (Option C ruled out) Indications: Cardiac Function in Chemotherapy : Evaluates cardiac function in patients receiving potentially cardiotoxic chemotherapy. Anatomical Assessment : Assesses the orientation of the heart and great vessels in the chest. Ischemic Disease Detection : Identifies undiagnosed ischemic disease in patients with hypodynamic wall motion without prior myocardial infarction. Heart Failure Evaluation : Determines systolic or diastolic dysfunction in undiagnosed congestive heart failure by analyzing ventricular filling and contraction. Valvular Function and COPD : Evaluates valve motion and associated ventricular function, cardiac function in patients with chronic obstructive pulmonary disease (COPD), and checks for intracardiac shunts Reference: https://www.ncbi.nlm.nih.gov/books/NBK539772/# https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2876979/ https://www.ncbi.nlm.nih.gov/books/NBK564365/#",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Cardiology-Ischemic Heart Disease"
    },
    {
      "q_no": 25,
      "question": "A 60-year-old male presents with chronic stable angina that has progressively worsened despite optimal medical therapy. He underwent myocardial stress testing, which indicated ischemia. What is the next best step in diagnosing the extent of his coronary artery disease?",
      "options": {
        "A": "Stress echocardiography",
        "B": "Myocardial perfusion imaging",
        "C": "Coronary angiography",
        "D": "Coronary computed tomography angiography"
      },
      "correct_answer": "C",
      "explanation": "Correct Answer: C) Coronary angiography Explanation: Coronary angiography is the “gold standard for diagnosing coronary artery disease” , especially in patients with ischemia detected on non-invasive stress testing, like myocardial stress imaging. It provides direct visualization of coronary artery stenoses , helps determine the severity of the disease, and allows for intervention planning, such as stent placement or coronary artery bypass surgery. Coronary Angiography : Visualizes coronary artery stenoses as luminal narrowings on a cine angiogram. The degree of stenosis is determined by comparing the most affected segment with a nearby \"normal\" segment. A stenosis greater than 50% is considered significant. Radial Access is preferred over the femoral route due to its safety and cost-effectiveness. Advantages include fewer access site complications, shorter hospital stays, and improved patient comfort with early ambulation. The optimal puncture site is 2–3 cm above the wrist crease, where the radial artery is most palpable. The puncture is performed using a 20 G cannula and needle assembly, following the Seldinger technique , which involves a through-and-through puncture of the radial artery. The guide wire is advanced retrogradely towards the heart, passing through the arch of the aorta to reach the root of the aorta, where the coronary arteries originate. The coronary arteries are the first vessels branching from the aorta, supplying oxygen and nutrients to the heart, and the Brachiocephalic trunk is the first branch of the Aortic Arch. Diagnostic Tests in Stable Angina Investigation Indications Limitations Exercise Treadmill Test Initial test for intermediate-risk patients without resting ECG abnormalities; used for risk stratification and diagnosis of CAD. Non-diagnostic in patients with LBBB, LVH, paced rhythm, or digoxin use. Stress Echocardiography (Option A) Used in patients who cannot exercise or have resting ECG abnormalities; preferred for evaluating LV function and ischemia. Image quality can be affected by obesity and COPD; technician-dependent. Myocardial Perfusion Imaging (Option B) Preferred for patients with prior revascularization, resting ECG abnormalities, or high risk of ischemia. Expensive; exposes patients to ionizing radiation. Cardiac Magnetic Resonance Imaging Indicated for comprehensive assessment of myocardial function, perfusion, structural heart disease, and subendocardial ischemia. Contraindicated in patients with metallic implants; long acquisition times. Coronary Computed Tomography Angiography (CCTA) (Option D) Alternative for patients with inconclusive ETT results or lower risk; also evaluates CABG patency and coronary artery anomalies. May not detect all critical stenoses; exposes patients to radiation. Coronary Angiography Gold standard for definitive diagnosis of CAD in patients with confirmed ischemia or medically refractory angina. Invasive, high cost,",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Cardiology-Ischemic Heart Disease"
    },
    {
      "q_no": 26,
      "question": "A 60-year-old male undergoes a treadmill ECG stress test and develops 2 mm of horizontal ST-segment depression after 8 minutes of exercise. He reports non-limiting chest pain (angina index = 1). What is his Duke Treadmill Score (DTS) and his risk category?",
      "options": {
        "A": "DTS = 0; Intermediate risk",
        "B": "DTS = 5; Low risk",
        "C": "DTS = -2; Intermediate risk",
        "D": "DTS = -8; High risk"
      },
      "correct_answer": "C",
      "explanation": "Correct Answer: C) DTS = -2; Intermediate risk. Explanation: Duke Treadmill Score (DTS) is calculated using the formula: DTS = Exercise time (in minutes) − (5× ST-segment deviation (in mm)) − (4 × angina index) The patient exercised for 8 minutes . There was 2 mm of horizontal ST-segment depression, so multiply by 5 . 5×2=10 The patient reported non-limiting chest pain, so the angina index = 1 (non-limiting angina). 4×1=4 Therefore, the DTS calculation: DTS = 8 − 10 − 4= − 2DTS This places the patient in the intermediate-risk category . Treadmill Test/ Modified Bruce protocol The individual is made to walk on a treadmill while gradually increasing the speed and inclination of the treadmill every 3 mins. Speed- 1.6 to 6 mph, with a gradual raise. It is a Non-invasive test with a Test sensitivity of 75% . Heart rate Response Maximum heart rate during exercise decreases with age, estimated by the formula: Maximum Predicted Heart Rate = 220 - age. Effort Threshold : Achieving 85% of age-predicted maximum heart rate is considered adequate effort during a treadmill ECG stress test. Blood Pressure Response Systolic BP Drop : A decrease of >10 mmHg may indicate myocardial ischemia or left ventricular dysfunction, requiring test termination. Exaggerated Response : Systolic BP > 210 mmHg in men and > 190 mmHg in women may predict future hypertension in normotensive individuals. ST-Segment Changes Abnormal Test : Horizontal or down-sloping ST-segment depression ≥ 1 mm at 60-80 ms after the J-point suggests obstructive coronary artery disease (CAD). Equivocal Test : Up-sloping ST-segment depression. Angina ST Segment Changes\" data-author=\"NA\" data-hash=\"8674\" data-license=\"NA\" data-source=\"NA\" data-tags=\"April2025\" height=\"299\" src=\"https://image.prepladder.com/notes/CpLUJ9CTvS0r9lt5NZGW1744298895.png\" width=\"299\" /> Contraindications Recent acute myocardial infarction (within 2-3 days). Unstable angina . Uncontrolled cardiac arrhythmias with symptoms or hemodynamic instability. Symptomatic severe aortic stenosis . Uncontrolled symptomatic heart failure. Acute pulmonary embolism or pulmonary infarction. Severe pulmonary hypertension. Acute myocarditis, pericarditis, or endocarditis. Acute aortic dissection . Duke Treadmill Score (DTS) Formula: Duke Treadmill Score = Exercise time – (5 × ST-segment deviation) – (4 × angina index). Exercise time (minutes). ST-segment deviation (mm). Angina index: 0 = no angina. 1 = non-limiting angina. 2 = exercise-limiting angina. Risk Interpretation: Risk DTS Interpretation Low Risk ≥ 5 No need for further coronary angiography. Intermediate Risk (Option C) +4 to –10 May need further tests, such as myocardial perfusion scanning or coronary angiography. High Risk < –10 Requires further investigation with coronary angiography. Reference: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4958709/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1123951/#",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Cardiology-Ischemic Heart Disease"
    },
    {
      "q_no": 27,
      "question": "An elderly male with a history of cigarette smoking and hypertension develops chest pain after an evening walk. The pain is relieved after lying down for a few minutes. A treadmill stress test reveals ST-segment depression. What is the most likely cause attributed to this clinical presentation?",
      "options": {
        "A": "Hypertrophic Cardiomyopathy",
        "B": "Prinzmetal Angina",
        "C": "Non-ST-Elevation Myocardial Infarction (NSTEMI)",
        "D": "Chronic Stable Angina"
      },
      "correct_answer": "D",
      "explanation": "Correct Answer: D) Chronic Stable Angina Explanation: Chronic stable angina occurs due to myocardial ischemia during exertion, especially in patients with risk factors such as smoking and hypertension. It is characterized by chest pain that is relieved by rest. ST-segment depression on the treadmill test suggests ischemia without infarction, consistent with stable angina. Chronic Stable Angina (Reversible Ischemia) Chronic stable angina, or exertional angina, is a type of ischemic heart disease that occurs when the heart muscle does not receive adequate oxygen due to reduced blood flow through the coronary arteries, especially during physical exertion or emotional stress. Incidence: M/c in males and postmenopausal females, particularly in individuals over the age of 60. Risk Factors: Smoking Hypertension Diabetes Hyperlipidemia Family history of coronary artery disease Clinical Features: Chest Pain (Angina Pectoris): The primary symptom is chest discomfort or pain, often described as a squeezing, tightness, or pressure sensation. Triggers: Commonly triggered by physical activity or emotional stress, which increase the heart's oxygen demand, leading to angina. Duration: Usually lasts 5 to 10 minutes. Relief: The pain typically resolves with rest or the use of sublingual nitroglycerin within a few minutes. ECG Findings: Asymptomatic Phase: The ECG is usually normal during rest or when the patient is not experiencing chest pain. Symptomatic Phase (During Angina): The hallmark ECG finding is ST-segment depression, indicating subendocardial ischemia due to insufficient blood flow to the inner layer of the heart muscle. Hypertrophic Cardiomyopathy (Option A): This condition usually presents with exertional dyspnea, syncope, or palpitations rather than chest pain. While it may cause ischemia, it is not typically associated with ST-segment depression on a treadmill test. Prinzmetal Angina (Option B): This type of angina is caused by coronary artery spasm and typically occurs at rest, often during nighttime or early morning. It can be associated with transient ST-segment elevation rather than depression. Non-ST-Elevation Myocardial Infarction (NSTEMI) (Option C): While NSTEMI can present with ST-segment depression, the chest pain is more persistent and not typically relieved by rest. Additionally, NSTEMI often shows elevated cardiac biomarkers, indicating myocardial injury. Reference: https://www.ncbi.nlm.nih.gov/books/NBK559016/",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Cardiology-Ischemic Heart Disease"
    },
    {
      "q_no": 28,
      "question": "Arrange the following structures of an atherosclerotic plaque from the innermost to the outermost layer: Fibrous cap Necrotic core Foam cell layer Media → Foam cell layer → Necrotic core → Media → Media → Foam cell layer → Fibrous cap → Fibrous cap → Media → Necrotic core → Necrotic core → Fibrous cap → Media",
      "options": {
        "A": "Fibrous cap",
        "B": "Necrotic core",
        "C": "Foam cell layer",
        "D": "Foam cell layer"
      },
      "correct_answer": "A",
      "explanation": "→ Foam cell layer → Necrotic core → Media Correct Answer: A) Fibrous cap → Foam cell layer → Necrotic core → Media Explanation: Atheromatous Plaque (labelled)\" data-author=\"Dr Vijay Shankar S \" data-hash=\"8669\" data-license=\"CC BY-NC-SA 3.0\" data-source=\"https://ilovepathology.com/pathology-of-atherosclerosis/\" data-tags=\"April2025\" height=\"292\" src=\"https://image.prepladder.com/notes/2FgJQZyi08HjVdxC2Nns1744298779.png\" width=\"487\" /> Structure of Atheromatous Plaque Endothelium The innermost arterial lining that regulates blood flow, prevents clot formation, and controls inflammation. Damage to the endothelium due to factors like hypertension, hyperlipidemia, and smoking initiates plaque formation. Fibrous Cap Smooth muscle cells from the media migrate to the intima and secrete collagen, forming a protective fibrous cap over the lipid core. Cap stability determines plaque vulnerability. Foamy Cell Layer Lipoproteins like LDL accumulate in the subendothelial space after endothelial injury. Macrophages engulf oxidized LDL, becoming foam cells, forming lipid-rich fatty streaks. Necrotic Core Foam cells die, releasing lipids and forming a necrotic core, consisting of dead cells and cholesterol crystals. A large necrotic core increases plaque instability. Media The smooth muscle-rich middle arterial layer thins and weakens during plaque development as muscle cells move to form the fibrous cap. Sequence of Atherosclerosis Development Endothelial Injury Damage to the arterial inner lining, often due to hypertension, smoking, diabetes, or highcholesterol. ↓ Lipid Accumulation Low-density lipoprotein (LDL) infiltrates the damaged endothelium and accumulates in the arterial wall. ↓ Inflammation Immune cells (macrophages) engulf lipids, forming foam cells and triggering inflammation. ↓ Plaque Formation Foam cells and lipids build up, creating a plaque with a necrotic core and a fibrous cap, narrowing the artery. ↓ Plaque Rupture Rupture of the fibrous cap can cause thrombosis, leading to artery obstruction and ischemic events like heart attack or stroke.",
      "image": "https://raw.githubusercontent.com/tk22kalal/mcqimage/main/pxmedicine/Cardiology-Ischemic_Heart_Disease_Q28_q.jpg",
      "explanation_image": null,
      "chapter_heading": "Cardiology-Ischemic Heart Disease"
    }
  ]
}
